These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years. Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417 [TBL] [Abstract][Full Text] [Related]
3. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
4. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study. Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487 [TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797 [TBL] [Abstract][Full Text] [Related]
6. Key elements in adverse drug interaction safety signals: an assessment of individual case safety reports. Strandell J; Norén GN; Hägg S Drug Saf; 2013 Jan; 36(1):63-70. PubMed ID: 23315297 [TBL] [Abstract][Full Text] [Related]
7. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis. Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078 [TBL] [Abstract][Full Text] [Related]
8. Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican Republic. Burke HM; Packer C; Fuchs R; Brache V; Bahamondes L; Salinas A; Veiga N; Miller A; Deese J Contraception; 2022 Sep; 113():95-100. PubMed ID: 35483431 [TBL] [Abstract][Full Text] [Related]
9. Injection Site Reactions Before and After Intramuscular Injection Technique Revision: A Postmarketing Analysis of NALDEBAIN® From 2017 to 2022. Man KM; Lee SO; Lu CH; Wong CS; Sun WZ Asian J Anesthesiol; 2023 Mar; 61(1):14-20. PubMed ID: 37160663 [TBL] [Abstract][Full Text] [Related]
10. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center. Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533 [TBL] [Abstract][Full Text] [Related]
11. Safety profile of etifoxine: A French pharmacovigilance survey. Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
13. Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®. Pokladnikova J; Meyboom RH; Meincke R; Niedrig D; Russmann S Drug Saf; 2016 May; 39(5):455-64. PubMed ID: 26936182 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302 [TBL] [Abstract][Full Text] [Related]
15. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Wallerstedt SM; Brunlöf G; Sundström A Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827 [TBL] [Abstract][Full Text] [Related]
16. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
17. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese. Inácio P; Airaksinen M; Cavaco A Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069 [TBL] [Abstract][Full Text] [Related]
18. Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings. Keith B; Wood S; Tifft S; Hutchings J Contraception; 2014 May; 89(5):344-51. PubMed ID: 24813924 [TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924 [TBL] [Abstract][Full Text] [Related]
20. Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy. Scavone C; Di Mauro C; Ruggiero R; Bernardi FF; Trama U; Aiezza ML; Rafaniello C; Capuano A Drugs Real World Outcomes; 2020 Mar; 7(1):41-51. PubMed ID: 31848905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]